ABVC BIOPHARMA, INC.
For the period ended Mar 31, 2026. Filed May 18, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 18, 2026
ABVC$0.97-0.2%Stored close · as of Nov 6, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-03.
0001213900-25-104811
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-18.
0001213900-26-058104
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 28 previous paragraphs and 12 current paragraphs.
9 unchanged; 0 reworded; 3 added; 19 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 3 previous and 3 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (3)
Current report
On January 12, 2026, the Company sold an aggregate amount of $256,000 on the same terms and conditions as the Reg S Offering; Pursuant to the share subscriptions, the Company has issued an aggregate of 131,280 shares of the Company’s common stock. The price at which the Shares were sold at $1.95 per share.
Current report
On January 9, 2026 and February 3, 2026, the Company issued 14,863, 16,753, and 28,389 shares, respectively, to settle January, February, and March 2026 rent balances of $34,155, $34,159, and $37,984, respectively.
Current report
Between January 13, 2026 and March 5, 2026, the Company issued an aggregate of 26,747 shares of common stock to various consultants for providing business services and funding opportunities, in the aggregate amount of $52,869.
Removed paragraphs (19)
Previous report
In July 2024, the Company entered into an agreement with its landlord in California, pursuant that the Company issued 169,992 shares of common stock for the rent payable through July 2024, in total of $127,494. The Company also issued 43,458 shares on August 14, 2024 for the August 2024 rent, and 46,072 shares were issued on September 3, 2024 for the September 2024 rent. Further, we issued 64,147 shares on October 29, 2024 for October rent, 45,293 shares on November 13, 2024 for November rent, and 30,422 shares on December 26, 2024 for half month of December rent. In 2025, we issued 28,135 shares, 22,031 shares, and 30,488 shares for each of the half month rent from January 2025 to March 2025, respectively. On April 9, 2025, the Company entered another agreement with the landlord to settle remaining balance of each half month of February and March 2025 rent, and April 2025 rent, by issuing 120,398 of the Company’s common stock, in the value of $66,219. On June 12, the Company issued 34,059 and 25,349 unregistered restricted shares to the landlord to settle May 2025 and June 2025 rent balances of $33,390 each month. On July 10, 2025, the Company issued 14,847 shares to settle July rent balance of $33,480. On August 22, 2025, the Company issued 11,486 shares to settle August rent balance of $33,482. On September 9, 2025, the Company issued 11,166 shares to settle September rent of $33,487.
Previous report
In December 2024, the Company issued 117,277 shares of its common stock to employees as compensation.
Previous report
In 2024, the Company received $31,040 from an investor to subscribe 41,387 shares of the Company’s common stock. These stocks were issued to the investor as of September 30, 2025.
Previous report
Between April 11, 2025 and April 30, 2025, the Company conducted a private offering of its common stock to several individual non-US investors, issued an aggregate of 724,372 unregistered shares of common stock at $0.60 to $0.65 per share, raising a total of $436,125.
Previous report
In April 2025, the Company issued 9,909 unregistered restricted shares to an individual consultant as a consideration of $9,800 for the services.
Previous report
In April 2025, the Company issued 50,000 shares of common stock to a consultant for the financial and business advisory services, as the consideration of $52,500 ($1.05 per share).
Previous report
In April 2025 and July 2025, the Company issued 90,277 and 59,723 shares of common stock to an employee to compensate her for additional services, amounting to $94,791 and $62,709 ($1.05 and $1.05 per share), respectively.
Previous report
Between April 30, 2025 and May 9, 2025, the Company sold an aggregate of 1,030,413 shares of its Common Stock to 22 Non-U.S. Persons. The Company received aggregate gross proceeds of approximately $619,625 for the shares.
Previous report
Between May 9, 2025 and May 13, 2025, the Company accepted subscriptions from an additional 7 Non-U.S. Persons on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 306,041 shares of the Company’s common stock, resulting in gross proceeds of approximately $183,625.
Previous report
On May 27, 2025, the Company accepted additional subscriptions in the aggregate amount of $670,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 957,144 shares of the Company’s common stock.
Previous report
Between May 26, 2025 and June 5, 2025, the Company accepted additional subscriptions in the aggregate amount of $579,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 579,000 shares of the Company’s common stock.
Previous report
On June 20, 2025, the Company accepted additional subscriptions in the aggregate amount of $170,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 130,771 shares of the Company’s common stock.
Previous report
On July 1, 2025, the Company accepted additional subscriptions in the aggregate amount of $30,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 23,079 shares of the Company’s common stock.
Previous report
On July 11, 2025, the Company accepted additional subscriptions in the aggregate amount of $200,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 153,850 shares of the Company’s common stock.
Previous report
On August 7, 2025, the Company accepted additional subscriptions in the aggregate amount of $508,250 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 260,641 shares of the Company’s common stock.
Previous report
On August 23, 2025, the Company issued 873 unregistered restricted shares to an individual consultant as a consideration of $2,500, for the services.
Previous report
On August 29, 2025, the Company accepted additional subscriptions in the aggregate amount of $200,000 on the same terms and conditions. Pursuant to the additional subscriptions, the Company issued an aggregate of 102,564 shares of the Company’s common stock.
Previous report
On October 7, 2025, the Company issued 10,749 shares to settle October rent balance of $33,480.
Previous report
On October 10, 2025, the Company issued an aggregate of 100,000 shares to employees and consultants.